Georgia's Online Cancer Information Center

Cecilia Hammond

Cecilia Hammond, MSN, RNS

Survivor and Advocate

Senior Genomic Science Liaison

Cecilia Hammond, MSN, RNS

Cecilia Hammond

Survivor and Advocate

Senior Genomic Science Liaison

Cecilia Hammond has lived in Georgia since 1994.  Diagnosed with stage IIIB breast cancer in 1996, she was the beneficiary of the excellent cancer care available in the state. Her 18 years as a cancer survivor have given her a unique perspective on the needs of survivors as they face the journey from diagnosis to treatment and follow-up care.

Mrs. Hammond received her bachelor’s degree in Nursing from Marshall University in Huntington, West Virginia. In 2013, working with Georgia CORE – the Center for Oncology Research and Education and the Cancer Patient Navigators of Georgia, she completed her master’s degree in Nursing from Benedictine University in Lisle, Illinois.

Mrs. Hammond has works as an oncology Medical Science Liaison with a major pharmaceutical company. In her role as a MSL, Mrs. Hammond works with cancer thought leaders to support cancer research and with patient advocacy organizations to provide education and support.  She is a member of the American Society of Clinical Oncology, Oncology Nursing Society, and Sigma Theta Tau (National Nurse Honor Society).

Mrs. Hammond lives in Alpharetta with her husband Steve.  She enjoys boating, reading, music, and exercising.  She combines her joy of exercise with fundraising efforts by participating in activities such as the Susan G. Komen Race for the Cure, The Avon 3-Day Breast Cancer Walk, and the 26.2 with Donna Breast Cancer Marathon.

Survivorship

Alabama embryo ruling may have devastating effect on cancer patients

Cancer patients concerned about their fertility and oncologists are expressing shock and anxiety about the recent ruling by the Alabama Supreme Court that frozen embryos are considered children under the law.

3/05/2024

Georgia CORE awards Cancer Research Fund grant to two teams

Georgia CORE has awarded two teams a Collaborative Cancer Research Seed Grant from the Georgia Cancer Research Fund.

5/10/2024